Showing results (1091-1100 of 1,712) with videos related to
Sort By:
Pageof 172
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 24, 1998
Analysis of prognostic factors in newly diagnosed acute promyelocytic leukemia treated with all-trans retinoic acid and chemotherapy. Japan Adult Leukemia Study GroupN Asou, K Adachi, J Tamura, et al.JAMA Network Open|November 18, 2025
Provision of Temporary Access to Inpatient Hemodialysis to Uninsured Patients Initiating HemodialysisJosh Banerjee, Hugh Gordon, Victoria E Walsh, et al.Diabetes, Obesity & Metabolism|December 27, 2016
Efficacy, safety and albuminuria-reducing effect of gemigliptin in Korean type 2 diabetes patients with moderate to severe renal impairment: A 12-week, double-blind randomized study (the GUARD Study)Sun A Yoon, Byoung G Han, Sung G Kim, et al.Telemedicine Journal and E-Health : the Official Journal of the American Telemedicine Association|October 1, 2016
Practice Guidelines for TeledermatologyKaren McKoy, Nina M Antoniotti, April Armstrong, et al.International Journal of Hematology|September 25, 1999
No beneficial effect from addition of etoposide to daunorubicin, cytarabine, and 6-mercaptopurine in individualized induction therapy of adult acute myeloid leukemia: the JALSG-AML92 study. Japan Adult Leukemia Study GroupS Miyawaki, M Tanimoto, T Kobayashi, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 1, 1996
Randomized trials between behenoyl cytarabine and cytarabine in combination induction and consolidation therapy, and with or without ubenimex after maintenance/intensification therapy in adult acute myeloid leukemia. The Japan Leukemia Study GroupT Kobayashi, S Miyawaki, M Tanimoto, et al.Oncogene|March 23, 2011
IL-32γ inhibits cancer cell growth through inactivation of NF-κB and STAT3 signalsJ H Oh, M-C Cho, J-H Kim, et al.European Review for Medical and Pharmacological Sciences|January 28, 2021
Body mass index and mortality in patients with cardiovascular disease: an umbrella review of meta-analysesR Abou Ghayda, D Duck-Young Park, J Y Lee, et al.ACS Chemical Biology|August 24, 2016
Small Molecule Inhibitor of NRF2 Selectively Intervenes Therapeutic Resistance in KEAP1-Deficient NSCLC TumorsAnju Singh, Sreedhar Venkannagari, Kyu H Oh, et al.International Journal of Impotence Research|June 6, 2003
A double-blind, randomised- placebo, controlled, parallel group, multicentre, flexible-dose escalation study to assess the efficacy and safety of sildenafil administered as required to male outpatients with erectile dysfunction in KoreaH K Choi, T Y Ahn, J J Kim, et al.Pageof 172